Big pharma now has the firepower advantage to pursue the M&A needed to address growth challenges in 2017.
EY M&A Outlook and Firepower Report 2017
Reshaping biopharmaceutical business models
Life sciences customer experience: what’s next?
Capital Confidence Barometer – Life sciences | 15th edition
Taking a risk-based approach to EU MDR compliance
Galvanizing innovation in medtech – and biopharma
New normal: US$200b+ M&A as big pharma leads way
As our population ages, how can we rein in rising costs?
Navigating Brexit in life sciences
The need for alignment to achieve health outcomes for all
As populations age and chronic diseases become commonplace, health care will take an ever larger share of GDP. Scientific progress, augmented intelligence and a more empowered patient are driving changes in the delivery of health care to a personalized experience that demands health outcomes as the core metric. This is causing a power shift among traditional stakeholder groups, with new entrants (often not driven by profit) disrupting incumbents.
Innovation, productivity and access to patients remain the industry’s biggest challenges. These trends challenge the capital strategy of every link in the life sciences value chain, from R&D and product supply to product launch and patient-centric operating models.
Our Global Life Sciences Sector brings together a worldwide network of 11,000 sector-focused professionals to anticipate trends, identify their implications and help our clients create competitive advantage. We can help you navigate your way forward and achieve sustainable success in the new health-outcomes-driven ecosystem.
- The Firepower Index and Growth Gap Report 2016
- Firepower Index and Growth Gap Report 2015: Focus, scale and growth drive explosive M&A
- Life Sciences: Global Corporate Divestment Study 2015
- Cash on prescription: Pharmaceutical companies and working capital management 2015
- Megatrends - Health reimagined
- Medical technology
| Lara Iob |
514 879 6514
Connect with us
Driving sustainable excellence in health care.
Empowered patients are demanding more. Big data and supply chains offer new challenges. EY has the vision to help solve the industry's most pressing issues.